Cargando…

Editorial: TNFRSF agonists: mode of action and therapeutic opportunities

Detalles Bibliográficos
Autores principales:	Obermajer, Nataša, Zwolak, Adam, Wajant, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660652/ https://www.ncbi.nlm.nih.gov/pubmed/38022660 http://dx.doi.org/10.3389/fimmu.2023.1328100

Ejemplares similares

Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
por: Wajant, Harald
Publicado: (2019)

TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity
por: Medler, Juliane, et al.
Publicado: (2019)

Editorial: Immunity to Cytomegalovirus Infections: Challenges and Therapeutic Opportunities
por: Alonso-Arias, Rebeca, et al.
Publicado: (2022)

Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
por: Zaitseva, Olena, et al.
Publicado: (2023)

Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer
por: Wajant, Harald, et al.
Publicado: (2019)

Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities
por: Wang, Man, et al.
Publicado: (2023)

TNFRSF13B Diversification Fueled by B Cell Responses to Environmental Challenges—A Hypothesis
por: Cascalho, Marilia, et al.
Publicado: (2021)

Vaccine Adjuvants: Mode of Action
por: De Gregorio, Ennio, et al.
Publicado: (2013)

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies
por: Lang, Isabell, et al.
Publicado: (2018)

Association of TNFRSF1B Promoter Polymorphisms with Human Disease: Further Studies Examining T-Regulatory Cells Are Required
por: Li, Hongchuan, et al.
Publicado: (2018)

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
por: Zaitseva, Olena, et al.
Publicado: (2023)

TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon Cancer Microenvironment: A Multiomics Integrative Analysis
por: Zhang, Jun-rong, et al.
Publicado: (2021)

TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1
por: Akagi, Takahiko, et al.
Publicado: (2022)

Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells
por: Ticha, Olga, et al.
Publicado: (2018)

TRAF2 Controls Death Receptor-Induced Caspase-8 Processing and Facilitates Proinflammatory Signaling
por: Kreckel, Jennifer, et al.
Publicado: (2019)

Modes of action and diagnostic value of miRNAs in sepsis
por: Antonakos, Nikolaos, et al.
Publicado: (2022)

Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action
por: Buckley, Paul R., et al.
Publicado: (2019)

Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in TNFRSF1A Gene
por: Ruiz-Ortiz, Estíbaliz, et al.
Publicado: (2017)

TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity
por: Valatas, Vassilis, et al.
Publicado: (2019)

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
por: Szabo, Attila
Publicado: (2015)

The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
por: Bayati, Fatemeh, et al.
Publicado: (2021)

Therapeutic potential of TNFR2 agonists: a mechanistic perspective
por: Chen, Yibo, et al.
Publicado: (2023)

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
por: van de Donk, Niels W.C.J., et al.
Publicado: (2018)

Erratum: Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action
Publicado: (2019)

Editorial: Breast milk: From nutrition to immunological action
por: Honorio-França, Adenilda Cristina, et al.
Publicado: (2022)

TNFα Causes a Shift in Gene Expression of TNFRSF1A and TNFRSF1B Isoforms
por: Perik-Zavodskaia, Olga, et al.
Publicado: (2023)

Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease
por: Grieshaber-Bouyer, Ricardo, et al.
Publicado: (2019)

Therapeutic Potential of Regulatory T Cells in Preeclampsia—Opportunities and Challenges
por: Robertson, Sarah A., et al.
Publicado: (2019)

Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
por: Sun, Yun, et al.
Publicado: (2021)

Three Novel Players: PTK2B, SYK, and TNFRSF21 Were Identified to Be Involved in the Regulation of Bovine Mastitis Susceptibility via GWAS and Post-transcriptional Analysis
por: Yang, Fan, et al.
Publicado: (2019)

TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK
por: Carmona Arana, José Antonio, et al.
Publicado: (2014)

TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2018)

Editorial: Effector functions of therapeutic antibodies
por: Boross, Peter, et al.
Publicado: (2023)

Editorial: Immunogenicity of Proteins Used as Therapeutics
por: Sauna, Zuben E., et al.
Publicado: (2020)

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs
por: von Gunten, Stephan, et al.
Publicado: (2023)

Next generations of CAR-T cells - new therapeutic opportunities in hematology?
por: Tomasik, Jaromir, et al.
Publicado: (2022)

Modes of Action for Mucosal Vaccine Adjuvants
por: Aoshi, Taiki
Publicado: (2017)

Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection
por: Murin, Charles D., et al.
Publicado: (2022)

Editorial: Advances in T Cell Therapeutic Vaccines for HIV
por: Macatangay, Bernard J. C., et al.
Publicado: (2022)

Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
por: Moll, Guido, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7cifvlk3b3tcnmdhudup8mm0a4